BackCellev8 Nutrition Overview
Cellev8 Nutrition Inc.

Cellev8 Nutrition Return on Equity

Latest ROE for Cellev8 Nutrition: 26.5% — see history and peer comparisons.

Get informed when a big investor buys or sells

+ Follow

ROE

26.50%

Return on Equity

26.50%

Return on Equity measures how efficiently a company uses shareholders' equity to generate profits. A higher ROE indicates better profitability relative to equity.

ROE (Comparison Companies)

Loading

ROE History

Loading

ROE Comparison

Loading

Cellev8 Nutrition (CELV) FAQ

The latest ROE for CELV is 26.5%. That is above the sector sector average of 11.3%. Investors often review this figure alongside Cellev8 Nutrition's historical trend and sector peers before judging valuation or financial health.

Against its sector companies, CELV currently prints 26.5% for ROE, while the sector average sits near 11.3%. That is roughly 134.6% above the sector mean. Large gaps often invite a closer look at Cellev8 Nutrition's growth, margins, and balance sheet.

Return on Equity shows how effectively Cellev8 Nutrition converts resources into returns. At 26.5%, CELV may look efficient or underperforming depending on peer benchmarks and trend direction. Pair the percentage with revenue growth and leverage for a fuller health check.

After noting CELV's ROE (26.5%), review year-over-year change, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.